Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 5, 2012, Pages 1410-1413

  Vasiadi, Magdalini ^a,b,c   Therianou, Anastasia ^d   Sideri, Kyriaki ^c   Smyrnioti, Marilena ^c   Sismanopoulos, Nikolaos ^a,c   Delivanis, Danae A ^a,g   Asadi, Shahrzad ^a   Katsarou Katsari, Alexandra ^d   Petrakopoulou, Theodora ^e   Theoharides, Athanasios ^f   Antoniou, Christina ^d   Papadavid, Evaggelia ^c   Stavrianeas, Nikolaos ^c   Kalogeromitros, Dimitrios ^c   Theoharides, Theoharis C ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e Oncology Hospital   (Greece)

^f Ano Toumba Polyclinic   (Greece)

^g UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; VASCULOTROPIN;

ADULT; ATOPIC DERMATITIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PSORIASIS; SCORING SYSTEM; SKIN BIOPSY;

EID: 84860463864     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.01.041     Document Type: Article

References (9)

1. E. Guttman-Yassky, K.E. Nograles, and J.G. Krueger Contrasting pathogenesis of atopic dermatitis and psoriasis, part I: clinical and pathologic concepts J Allergy Clin Immunol 127 2011 1110 1118
2. M. Metz, M.A. Grimbaldeston, S. Nakae, A.M. Piliponsky, M. Tsai, and S.J. Galli Mast cells in the promotion and limitation of chronic inflammation Immunol Rev 217 2007 304 328
3. T.C. Theoharides, and D.E. Cochrane Critical role of mast cells in inflammatory diseases and the effect of acute stress J Neuroimmunol 146 2004 1 12
4. T.C. Theoharides, L.K. Singh, W. Boucher, X. Pang, R. Letourneau, and E. Webster Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects Endocrinology 139 1998 403 413
5. R. Crompton, V.L. Clifton, A.T. Bisits, M.A. Read, R. Smith, and I.M. Wright Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways J Clin Endocrinol Metab 88 2003 5427 5432
6. A. Slominski, and J. Wortsman Neuroendocrinology of the skin Endocr Rev 21 2000 457 487
7. A. Slominski On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders Br J Dermatol 160 2009 229 232
8. K.N. Fountoulakis, M. Papadopoulou, S. Kleanthous, A. Papadopoulou, V. Bizeli, and I. Nimatoudis Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data Ann Gen Psychiatry 5 2006 2
9. S. Asadi, K.D. Alysandratos, A. Angelidou, A. Miniati, N. Sismanopoulos, and M. Vasiadi Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells J Invest Dermatol 132 2012 324 329